Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Cyclophosphamide Systemic Sclerosis Associated Interstitial Lung Disease (SCLEROCYC)

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2014 by Assistance Publique - Hôpitaux de Paris
Sponsor:
Collaborator:
Service de Médecine Interne de l'hôpital Claude-Huriez, Lille, France - Pr David Launay
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier:
NCT01570764
First received: April 2, 2012
Last updated: January 2, 2014
Last verified: January 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2016
  Estimated Primary Completion Date: January 2016 (Final data collection date for primary outcome measure)